​Rajiv Khanna, shareholder in the firm's Corporate section, and Audrey Distler, associate, and Bruce Booken, shareholder in the Tax section, advised client Dr. Reddy's Laboratories in the $110 million sale of two neurology products. Dr. Reddy's Laboratories entered into a definitive agreement with Upsher-Smith Laboratories to sell the U.S. and select territory rights of its neurology branded products, Tosymra and Zembrace, for more than $110 million.

Read more in Economic Times' article "Dr Reddy's Sells Two Neurology Products in $110 Million Deal."